A cost-effectiveness analysis of screening for chronic kidney disease (CKD) has found that screening all adults in the United States starting at age 35 could be cost-effective for the quality of life-years (QALY) gained. ...
May 22, 2023
0
2
(HealthDay)—Medicare could save billions of dollars if secondary fractures could be prevented with improved osteoporosis screening, according to a new National Osteoporosis Foundation report conducted by Milliman.
Oct 2, 2019
1
3
A study published today (January 6) in the Annals of Internal Medicine finds that health care bureaucracy cost Americans $812 billion in 2017. This represented more than one-third (34.2%) of total expenditures for doctor ...
Jan 7, 2020
0
5
A dozen recommendations to ensure that Medicare beneficiaries have access to high-quality, coordinated care were provided today by the American College of Physicians (ACP). The new policy paper, Reforming Medicare in the ...
Apr 20, 2012
0
0
The decision this week by experts at the Food and Drug Administration to endorse a pair of medicines aimed at combating heart disease brought on the latest round of hand-wringing over prescription drug costs.
Jun 15, 2015
1
12
A new assessment of the Medicare Part D program based on a proposal from the West Health Policy Center finds that Medicare beneficiaries would save $29 billion if drug manufacturer rebates were used to reduce their out-of-pocket ...
Dec 19, 2019
0
1
Nursing home residents with advanced dementia commonly experience burdensome, costly interventions that do not improve their quality of life or extend their survival. Now a new study suggests that providing intensive primary ...
Sep 23, 2013
0
0
Patients are less likely to fill prescriptions for naloxone when they face increases in out-of-pocket costs, according to research by the University of Michigan.
Jun 14, 2024
0
5
Three times a week, Tod Gervich injects himself with Copaxone, a prescription drug that can reduce the frequency of relapses in people who have some forms of multiple sclerosis. After more than 20 years with the disease, ...
Apr 2, 2019
0
1
For nearly 10 years, Stacie Dusetzina, Ph.D., a Vanderbilt University professor of Health Policy and Ingram Professor of Cancer Research, has focused her research on one core policy issue that has been of interest to lawmakers ...
Nov 3, 2022
0
2
